𝔖 Bobbio Scriptorium
✦   LIBER   ✦

3502 ORAL Final results of a randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)

✍ Scribed by S.E. Al-Batran; J.T. Hartmann; S. Probst; R. Hofheinz; J. Stoehlmacher; C. Pauligk; S. Hollerbach; G. Schuch; N. Homann; E. Jäger

Book ID
118625847
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
76 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3010 ORAL Final overall survival (OS) re
3010 ORAL Final overall survival (OS) results of CONFIRM 1 (CF1), a randomized, double-blind, placebo-controlled phase III trial in patients with metastatic adenocarcinoma of the colon or rectum (mCRC) receiving first line chemotherapy with oxaliplatin/5-fluorouracil/Leucovorin (FOLFOX 4) and PTK787/ZK 222584 (PTK/ZK) or placebo (PBO)
✍ J.R. Hecht; T. Trarbach; E. Jaeger; J. Hainsworth; R.A. Wolff; K. Lloyd; G. Bodo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB